首页 > 最新文献

Hemodialysis International最新文献

英文 中文
The Use of Nocturnal Home Hemodialysis in Sickle Cell Disease 夜间家庭血液透析在镰状细胞病中的应用
IF 1.2 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2025-03-11 DOI: 10.1111/hdi.13224
Ryan J. Chan, Daniela Arustei, Christopher T. Chan

Introduction

Despite being a rare cause of end-stage kidney disease (ESKD), sickle cell disease has broad kidney implications. Patients with both sickle cell disease and ESKD are at a greater risk of adverse events including mortality; while these patients can be managed with hemodialysis (HD), the use of nocturnal HD in sickle cell disease has not been previously described.

Methods

Here, we report a patient with sickle cell disease and ESKD who transitioned from conventional HD to nocturnal home HD.

Findings

Following the initiation of extended HD, we observed a significant improvement in her blood pressure (BP) parameters, serum potassium levels, and volume status. We describe the importance of nitric oxide (NO) in maintaining normal endothelial function, and how NO bioavailability is disrupted in both the sickle cell disease and ESKD populations. We speculated that our patient had significant vasoconstriction secondary to NO depletion causing uncontrolled hypertension and intravascular hemolysis (leading to recurrent hyperkalemia), and theorized that extended HD could have enhanced the bioavailability of NO, restoring the vasodilatory capability of her endothelium.

Discussion

Having a dialysis modality that counters the negative pathophysiologic endothelial changes in sickle cell disease and ESKD could result in fewer complications in this vulnerable population.

简介:尽管镰状细胞病是终末期肾脏疾病(ESKD)的罕见病因,但它具有广泛的肾脏影响。同时患有镰状细胞病和ESKD的患者发生包括死亡在内的不良事件的风险更高;虽然这些患者可以通过血液透析(HD)进行治疗,但夜间血液透析在镰状细胞病中的应用以前没有报道。方法:在这里,我们报告了一个镰状细胞病和ESKD患者从传统HD过渡到夜间家庭HD。结果:在开始延长HD治疗后,我们观察到她的血压(BP)参数、血清钾水平和容积状态有显著改善。我们描述了一氧化氮(NO)在维持正常内皮功能中的重要性,以及NO在镰状细胞病和ESKD人群中的生物利用度是如何被破坏的。我们推测,我们的患者有明显的血管收缩继发于一氧化氮的消耗,导致不受控制的高血压和血管内溶血(导致复发性高钾血症),并推测延长的HD可能提高了一氧化氮的生物利用度,恢复了内皮的血管扩张能力。讨论:采用透析方式对抗镰状细胞病和ESKD的阴性病理生理性内皮改变可以减少这一易感人群的并发症。
{"title":"The Use of Nocturnal Home Hemodialysis in Sickle Cell Disease","authors":"Ryan J. Chan,&nbsp;Daniela Arustei,&nbsp;Christopher T. Chan","doi":"10.1111/hdi.13224","DOIUrl":"10.1111/hdi.13224","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Despite being a rare cause of end-stage kidney disease (ESKD), sickle cell disease has broad kidney implications. Patients with both sickle cell disease and ESKD are at a greater risk of adverse events including mortality; while these patients can be managed with hemodialysis (HD), the use of nocturnal HD in sickle cell disease has not been previously described.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Here, we report a patient with sickle cell disease and ESKD who transitioned from conventional HD to nocturnal home HD.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Findings</h3>\u0000 \u0000 <p>Following the initiation of extended HD, we observed a significant improvement in her blood pressure (BP) parameters, serum potassium levels, and volume status. We describe the importance of nitric oxide (NO) in maintaining normal endothelial function, and how NO bioavailability is disrupted in both the sickle cell disease and ESKD populations. We speculated that our patient had significant vasoconstriction secondary to NO depletion causing uncontrolled hypertension and intravascular hemolysis (leading to recurrent hyperkalemia), and theorized that extended HD could have enhanced the bioavailability of NO, restoring the vasodilatory capability of her endothelium.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion</h3>\u0000 \u0000 <p>Having a dialysis modality that counters the negative pathophysiologic endothelial changes in sickle cell disease and ESKD could result in fewer complications in this vulnerable population.</p>\u0000 </section>\u0000 </div>","PeriodicalId":12815,"journal":{"name":"Hemodialysis International","volume":"29 3","pages":"423-426"},"PeriodicalIF":1.2,"publicationDate":"2025-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143607613","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effect of Frailty on Quality of Life in Older Patients Receiving Hemodialysis and Associations With Fear of Falling 衰弱对老年血液透析患者生活质量的影响及其与跌倒恐惧的关系。
IF 1.2 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2025-03-10 DOI: 10.1111/hdi.13228
Zülfünaz Özer, Gülcan Bahçecioğlu Turan, Seda Başak

Purpose

This study investigated the effect of frailty and avoidance behavior due to fear of falling on the quality of life in older patients receiving hemodialysis treatment.

Methods

This study is cross-sectional and descriptive. The study was conducted between January 2 and 31, 2022, with 154 individuals aged 65 years and over receiving treatment in dialysis centers. The study data were collected using the Patient Information Form, Edmonton Frail Scale, Fear of Falling Avoidance-Behavior Questionnaire, and Quality of Life Scale (SF-12).

Results

The Mean Edmonton Frail Scale score was found to be 8.7 ± 3.36, the mean Fear of Falling Avoidance-Behavior Questionnaire score was found to be 33.17 ± 9.11, the mean SF-12 physical component score was found to be 34.32 ± 8.51, and the mean mental component score was seen as 41.77 ± 8.35. The Fear of Falling Avoidance-Behavior Questionnaire was an associated factor in the effect of the Edmonton Frail Scale on quality of life. It strengthened the negative impact of the Edmonton Frail Scale on quality of life. The predictive effect of these two variables in explaining quality of life was 59.3%.

Conclusion

It was found that the participants had moderate levels of frailty, moderate levels of activity limitation, and participation restriction due to fear of falling, and low levels of physical and mental quality of life. It was determined that frailty had a direct impact on quality of life. Also, the indirect effect of frailty on quality of life was determined through the role of avoidance behavior due to fear of falling.

目的:探讨老年血液透析患者因害怕跌倒而产生的虚弱和回避行为对生活质量的影响。方法:本研究采用横断面描述性方法。该研究于2022年1月2日至31日进行,共有154名65岁及以上的患者在透析中心接受治疗。研究数据采用患者信息表、埃德蒙顿虚弱量表、害怕避免跌倒行为问卷和生活质量量表(SF-12)收集。结果:埃德蒙顿体弱量表平均得分为8.7±3.36分,害怕坠落回避行为问卷平均得分为33.17±9.11分,SF-12身体成分平均得分为34.32±8.51分,心理成分平均得分为41.77±8.35分。在埃德蒙顿体弱量表对生活质量的影响中,恐惧逃避行为问卷是一个相关因素。它加强了埃德蒙顿虚弱量表对生活质量的负面影响。这两个变量解释生活质量的预测效应为59.3%。结论:研究发现,参与者存在中度虚弱,中度活动限制和因害怕跌倒而限制参与,身心生活质量较低。人们确定,虚弱对生活质量有直接影响。此外,虚弱对生活质量的间接影响是通过由于害怕跌倒而导致的回避行为的作用来确定的。
{"title":"The Effect of Frailty on Quality of Life in Older Patients Receiving Hemodialysis and Associations With Fear of Falling","authors":"Zülfünaz Özer,&nbsp;Gülcan Bahçecioğlu Turan,&nbsp;Seda Başak","doi":"10.1111/hdi.13228","DOIUrl":"10.1111/hdi.13228","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Purpose</h3>\u0000 \u0000 <p>This study investigated the effect of frailty and avoidance behavior due to fear of falling on the quality of life in older patients receiving hemodialysis treatment.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This study is cross-sectional and descriptive. The study was conducted between January 2 and 31, 2022, with 154 individuals aged 65 years and over receiving treatment in dialysis centers. The study data were collected using the Patient Information Form, Edmonton Frail Scale, Fear of Falling Avoidance-Behavior Questionnaire, and Quality of Life Scale (SF-12).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The Mean Edmonton Frail Scale score was found to be 8.7 ± 3.36, the mean Fear of Falling Avoidance-Behavior Questionnaire score was found to be 33.17 ± 9.11, the mean SF-12 physical component score was found to be 34.32 ± 8.51, and the mean mental component score was seen as 41.77 ± 8.35. The Fear of Falling Avoidance-Behavior Questionnaire was an associated factor in the effect of the Edmonton Frail Scale on quality of life. It strengthened the negative impact of the Edmonton Frail Scale on quality of life. The predictive effect of these two variables in explaining quality of life was 59.3%.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>It was found that the participants had moderate levels of frailty, moderate levels of activity limitation, and participation restriction due to fear of falling, and low levels of physical and mental quality of life. It was determined that frailty had a direct impact on quality of life. Also, the indirect effect of frailty on quality of life was determined through the role of avoidance behavior due to fear of falling.</p>\u0000 </section>\u0000 </div>","PeriodicalId":12815,"journal":{"name":"Hemodialysis International","volume":"29 3","pages":"371-380"},"PeriodicalIF":1.2,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143598517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endogenous Bacterial Endophthalmitis Complicating Hemodialysis Catheter-Related Sepsis: A Case Report and Review of the Literature 内源性细菌性眼内炎并发血液透析导管相关性脓毒症1例报告及文献复习。
IF 1.2 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2025-03-08 DOI: 10.1111/hdi.13226
Hui Guo, Dingyu Zhu, Yonglan Wang, Miao Ding, Yanyun Jiang, Xiaoxia Wang

Background

Endogenous endophthalmitis is an infrequent yet severe complication of hemodialysis catheter-related sepsis. In this report, we present a case of endogenous bacterial endophthalmitis in a patient with hemodialysis catheter-related sepsis.

Case Presentation

A 65-year-old male had a history of hepatitis B-related glomerulonephritis, end-stage renal disease, hepatitis-B-related decompensated cirrhosis, hypertension, diabetes mellitus, and coronary artery disease. He received temporary central venous catheterization and commenced hemodialysis. Subsequent diagnosis of methicillin-resistant Staphylococcus aureus (MRSA) endogenous endophthalmitis originating from catheter-related bloodstream infection (CRBSI) was established. The patient underwent vitrectomy and received intravitreal antibiotic injections. Treatment with systemic and local antibiotics was sustained for a duration of 4 weeks, however, the patient's visual acuity remained poor.

Conclusions

Endogenous endophthalmitis represents a vision-threatening emergency necessitating rapid identification and intervention. Clinicians should maintain a high index of suspicion for endogenous endophthalmitis when ocular symptoms manifest in the context of sepsis. Timely ophthalmological evaluation and management are imperative to optimize patient outcomes.

Endogenous endophthalmitis represents a vision-threatening emergency necessitating rapid identification and intervention. Clinicians should maintain a high index of suspicion for endogenous endophthalmitis when ocular symptoms manifest in the context of sepsis. Timely ophthalmological evaluation and management are imperative to optimize patient outcomes.

背景:内源性眼内炎是血液透析导管相关性败血症的一种少见但严重的并发症。在这个报告中,我们提出一个病例内源性细菌性眼内炎患者与血液透析导管相关的败血症。病例介绍:65岁男性,有乙型肝炎相关肾小球肾炎、终末期肾病、乙型肝炎相关失代偿性肝硬化、高血压、糖尿病和冠状动脉疾病病史。他接受了临时中心静脉置管并开始血液透析。随后诊断为耐甲氧西林金黄色葡萄球菌(MRSA)内源性眼内炎,起源于导管相关性血流感染(CRBSI)。患者行玻璃体切除术并接受玻璃体内抗生素注射。全身和局部抗生素治疗持续4周,但患者的视力仍然很差。结论:内源性眼内炎是一种威胁视力的急症,需要快速识别和干预。当眼部症状出现在脓毒症的背景下时,临床医生应保持对内源性眼内炎的高度怀疑。及时的眼科评估和管理是优化患者预后的必要条件。内源性眼内炎是一种威胁视力的紧急情况,需要快速识别和干预。当眼部症状出现在脓毒症的背景下时,临床医生应保持对内源性眼内炎的高度怀疑。及时的眼科评估和管理是优化患者预后的必要条件。
{"title":"Endogenous Bacterial Endophthalmitis Complicating Hemodialysis Catheter-Related Sepsis: A Case Report and Review of the Literature","authors":"Hui Guo,&nbsp;Dingyu Zhu,&nbsp;Yonglan Wang,&nbsp;Miao Ding,&nbsp;Yanyun Jiang,&nbsp;Xiaoxia Wang","doi":"10.1111/hdi.13226","DOIUrl":"10.1111/hdi.13226","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Endogenous endophthalmitis is an infrequent yet severe complication of hemodialysis catheter-related sepsis. In this report, we present a case of endogenous bacterial endophthalmitis in a patient with hemodialysis catheter-related sepsis.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Case Presentation</h3>\u0000 \u0000 <p>A 65-year-old male had a history of hepatitis B-related glomerulonephritis, end-stage renal disease, hepatitis-B-related decompensated cirrhosis, hypertension, diabetes mellitus, and coronary artery disease. He received temporary central venous catheterization and commenced hemodialysis. Subsequent diagnosis of methicillin-resistant \u0000 <i>Staphylococcus aureus</i>\u0000 (MRSA) endogenous endophthalmitis originating from catheter-related bloodstream infection (CRBSI) was established. The patient underwent vitrectomy and received intravitreal antibiotic injections. Treatment with systemic and local antibiotics was sustained for a duration of 4 weeks, however, the patient's visual acuity remained poor.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Endogenous endophthalmitis represents a vision-threatening emergency necessitating rapid identification and intervention. Clinicians should maintain a high index of suspicion for endogenous endophthalmitis when ocular symptoms manifest in the context of sepsis. Timely ophthalmological evaluation and management are imperative to optimize patient outcomes.</p>\u0000 \u0000 <p>Endogenous endophthalmitis represents a vision-threatening emergency necessitating rapid identification and intervention. Clinicians should maintain a high index of suspicion for endogenous endophthalmitis when ocular symptoms manifest in the context of sepsis. Timely ophthalmological evaluation and management are imperative to optimize patient outcomes.</p>\u0000 </section>\u0000 </div>","PeriodicalId":12815,"journal":{"name":"Hemodialysis International","volume":"29 3","pages":"404-409"},"PeriodicalIF":1.2,"publicationDate":"2025-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/hdi.13226","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143588984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hemodialysis Nonattendance: Patient Characteristics and Outcomes in a Single Renal Center in North West England 血液透析缺勤:英格兰西北部单一肾脏中心的患者特征和结果。
IF 1.2 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2025-03-06 DOI: 10.1111/hdi.13227
Rajkumar Chinnadurai, Jessica Dean, Sharmilee Rengarajan, Julie Gorton, Ivona Baricevic-Jones, Philip A. Kalra, Dimitrios Poulikakos

Introduction

Nonattendance for prescribed hemodialysis (HD) sessions is a form of nonadherence that compromises the delivery of life-sustaining HD therapy and is associated with severe morbidity and mortality. In this study, we aimed to assess the characteristics and outcomes of HD nonattenders in a single renal center in the North West of England.

Methods

HD patients followed by the renal team at our unit between December 2020 and September 2022 were included in this study. Dialysis nonattendance data were retrieved from the incident reports (DATIX) between December 2020 and November 2022, excluding dialysis nonattendance due to concurrent hospitalization. The cohort was split into group 1: no dialysis nonattendance; group 2: two or fewer dialysis nonattendances; and group 3: more than two dialysis nonattendances for comparative analysis. All patients were followed up for outcomes including all-cause mortality, transplantation, and hospitalizations until the study endpoint date of 12/31/2023. Predictors of dialysis nonattendance were identified using logistic regression.

Results

Of the 464 patients, dialysis nonattendance was noted in 149 (32%) patients, of which 79 (17%) had two dialysis nonattendance episodes and 70 (15%) had more than two dialysis nonattendance episodes. Over a median follow-up of 35 months, patients in group 3 had a higher hospitalization episode (4 vs. 1 day, p < 0.001) and lower kidney transplantation rates (4.3% vs. 13%, p = 0.038) compared to patients in group 1. In multivariate regression analysis, younger age (OR: 0.97; 95% CI: 0.95–0.98; p = 0.001), history of smoking (OR: 2.01; 95% CI: 1.12–3.62; p = 0.019), alcohol excess history (OR: 3.49; 95% CI: 1.87–6.49; p < 0.001) and history of mental health illness (OR: 3.01; 95% CI: 1.61–5.62; p = 0.001) were significant predictors of dialysis nonattendance.

Conclusion

Skipping HD is a common phenomenon associated with mental health issues and is associated with increased morbidity. Further research is required to understand the psychosocial determinants of nonadherence and effective models of intervention developed to improve outcomes.

不参加规定的血液透析(HD)疗程是一种不依从的形式,损害了维持生命的HD治疗的交付,并与严重的发病率和死亡率相关。在这项研究中,我们旨在评估英格兰西北部单一肾脏中心的HD非参与者的特征和结果。方法:本研究纳入了2020年12月至2022年9月期间在我单位肾脏组随访的HD患者。从2020年12月至2022年11月的事件报告(DATIX)中检索透析缺勤数据,不包括因同时住院而导致的透析缺勤。该队列被分为第一组:无透析,不出席;第2组:两次或更少的透析缺席;第三组:两次以上未透析患者进行比较分析。所有患者的随访结果包括全因死亡率、移植和住院情况,直到研究终点日期2023年12月31日。使用逻辑回归确定透析缺勤的预测因素。结果:在464例患者中,149例(32%)患者不参加透析,其中79例(17%)有两次透析不参加,70例(15%)有两次以上透析不参加。在中位35个月的随访中,第3组患者住院次数较高(4天vs 1天)。结论:跳过HD是一种与心理健康问题相关的常见现象,并与发病率增加有关。需要进一步的研究来了解不依从的社会心理决定因素和开发有效的干预模式以改善结果。
{"title":"Hemodialysis Nonattendance: Patient Characteristics and Outcomes in a Single Renal Center in North West England","authors":"Rajkumar Chinnadurai,&nbsp;Jessica Dean,&nbsp;Sharmilee Rengarajan,&nbsp;Julie Gorton,&nbsp;Ivona Baricevic-Jones,&nbsp;Philip A. Kalra,&nbsp;Dimitrios Poulikakos","doi":"10.1111/hdi.13227","DOIUrl":"10.1111/hdi.13227","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Nonattendance for prescribed hemodialysis (HD) sessions is a form of nonadherence that compromises the delivery of life-sustaining HD therapy and is associated with severe morbidity and mortality. In this study, we aimed to assess the characteristics and outcomes of HD nonattenders in a single renal center in the North West of England.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>HD patients followed by the renal team at our unit between December 2020 and September 2022 were included in this study. Dialysis nonattendance data were retrieved from the incident reports (DATIX) between December 2020 and November 2022, excluding dialysis nonattendance due to concurrent hospitalization. The cohort was split into group 1: no dialysis nonattendance; group 2: two or fewer dialysis nonattendances; and group 3: more than two dialysis nonattendances for comparative analysis. All patients were followed up for outcomes including all-cause mortality, transplantation, and hospitalizations until the study endpoint date of 12/31/2023. Predictors of dialysis nonattendance were identified using logistic regression.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Of the 464 patients, dialysis nonattendance was noted in 149 (32%) patients, of which 79 (17%) had two dialysis nonattendance episodes and 70 (15%) had more than two dialysis nonattendance episodes. Over a median follow-up of 35 months, patients in group 3 had a higher hospitalization episode (4 vs. 1 day, <i>p</i> &lt; 0.001) and lower kidney transplantation rates (4.3% vs. 13%, <i>p</i> = 0.038) compared to patients in group 1. In multivariate regression analysis, younger age (OR: 0.97; 95% CI: 0.95–0.98; <i>p</i> = 0.001), history of smoking (OR: 2.01; 95% CI: 1.12–3.62; <i>p</i> = 0.019), alcohol excess history (OR: 3.49; 95% CI: 1.87–6.49; <i>p</i> &lt; 0.001) and history of mental health illness (OR: 3.01; 95% CI: 1.61–5.62; <i>p</i> = 0.001) were significant predictors of dialysis nonattendance.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Skipping HD is a common phenomenon associated with mental health issues and is associated with increased morbidity. Further research is required to understand the psychosocial determinants of nonadherence and effective models of intervention developed to improve outcomes.</p>\u0000 </section>\u0000 </div>","PeriodicalId":12815,"journal":{"name":"Hemodialysis International","volume":"29 3","pages":"363-370"},"PeriodicalIF":1.2,"publicationDate":"2025-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/hdi.13227","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143574384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Concurrent Control of Sodium and Bicarbonate Serum Concentrations Using a Four-Stream Hemodialysis Fluid Delivery System 使用四流血液透析液输送系统同时控制钠和碳酸氢盐血清浓度。
IF 1.2 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2025-03-06 DOI: 10.1111/hdi.13205
Deepak Malhotra, Susie Q. Lew, Raymond E. Garrett, Ramin Sam, Robert H. Glew, Todd S. Ing, Antonios H. Tzamaloukas

Background

Previously, two reports proposed a four-stream dialysis fluid delivery system consisting of an acid concentrate, a base concentrate, a sodium chloride concentrate, and product water for correcting dysnatremias and metabolic acid–base disorders separately, by hemodialysis.

Methods

This report describes a new method for the clinical use of the previously reported four-stream dialysis fluid delivery system to treat concurrently dysnatremias and metabolic acid–base disturbances by hemodialysis. Pumps attached to each concentrate are designed to control its flow rate. Formulas were derived to determine the flow rate of each of the pumps controlling the flows of the product water ( W ), the base concentrate ( B ), and the sodium chloride concentrate ( S ) for any prescribed combination of sodium and bicarbonate concentrations is the final dialysis fluid. In this scheme, the flow rate of the acid concentrate ( A ), the concentrations of its contents in the final dialysis fluid remain constant. The flow rate ratio W:S:B:A remains also constant at 45 (i.e., 45X).

Results

The formulas were entered in an EXCEL flow sheet which determines the flow rate ratio W:S:B:A for any desired combination of sodium and bicarbonate concentrations in the dialysis fluid. The upper and lower limits of the concentrations of sodium and bicarbonate in the dialysis fluid were computed. The system has not been applied clinically. Measurements of any electrolyte concentrations have not been made.

Discussion

This system makes the treatment of profound dysnatremias, metabolic acid–base disorders, and combined dysnatremias and metabolic acid–base disorders feasible. The clinical application of the system demands prior in vitro or ex vivo studies plus fastidious and expert attention to ensure safe and dependable application.

背景:此前有两篇报道提出了一种由酸浓缩物、碱浓缩物、氯化钠浓缩物和产品水组成的四流透析液体输送系统,通过血液透析分别用于纠正钠血症和代谢性酸碱紊乱。方法:本报告描述了一种新的方法,用于临床使用先前报道的四流透析液体输送系统治疗血液透析并发钠血症和代谢性酸碱紊乱。每个浓缩物的泵都是用来控制其流量的。导出公式以确定控制产品水(W)、碱浓缩物(B)和氯化钠浓缩物(S)流量的每个泵的流量,钠和碳酸氢盐浓度的任何规定组合是最终的透析液。在此方案中,酸浓缩液的流速(A),其含量在最终透析液中的浓度保持不变。流量比W:S:B:A也保持45不变(即45X)。结果:将公式输入到EXCEL流程图中,该流程图确定透析液中钠和碳酸氢盐浓度的任何所需组合的流速比W:S:B:A。计算了透析液中钠和碳酸氢盐浓度的上限和下限。该系统尚未在临床上应用。没有对任何电解质浓度进行测量。讨论:该系统使深度钠代谢异常、代谢性酸碱紊乱以及钠代谢异常与代谢性酸碱紊乱合并治疗成为可能。该系统的临床应用需要事先进行体外或离体研究,加上严格的专家关注,以确保安全可靠的应用。
{"title":"Concurrent Control of Sodium and Bicarbonate Serum Concentrations Using a Four-Stream Hemodialysis Fluid Delivery System","authors":"Deepak Malhotra,&nbsp;Susie Q. Lew,&nbsp;Raymond E. Garrett,&nbsp;Ramin Sam,&nbsp;Robert H. Glew,&nbsp;Todd S. Ing,&nbsp;Antonios H. Tzamaloukas","doi":"10.1111/hdi.13205","DOIUrl":"10.1111/hdi.13205","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Previously, two reports proposed a four-stream dialysis fluid delivery system consisting of an acid concentrate, a base concentrate, a sodium chloride concentrate, and product water for correcting dysnatremias and metabolic acid–base disorders separately, by hemodialysis.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This report describes a new method for the clinical use of the previously reported four-stream dialysis fluid delivery system to treat concurrently dysnatremias and metabolic acid–base disturbances by hemodialysis. Pumps attached to each concentrate are designed to control its flow rate. Formulas were derived to determine the flow rate of each of the pumps controlling the flows of the product water (<b>\u0000 <i>W</i>\u0000 </b>), the base concentrate (<b>\u0000 <i>B</i>\u0000 </b>), and the sodium chloride concentrate (<b>\u0000 <i>S</i>\u0000 </b>) for any prescribed combination of sodium and bicarbonate concentrations is the final dialysis fluid. In this scheme, the flow rate of the acid concentrate (<b>\u0000 <i>A</i>\u0000 </b>), the concentrations of its contents in the final dialysis fluid remain constant. The flow rate ratio <b>\u0000 <i>W</i>:<i>S</i>:<i>B</i>:<i>A</i>\u0000 </b> remains also constant at 45 (i.e., 45X).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The formulas were entered in an EXCEL flow sheet which determines the flow rate ratio <b>\u0000 <i>W</i>:<i>S</i>:<i>B</i>:<i>A</i>\u0000 </b> for any desired combination of sodium and bicarbonate concentrations in the dialysis fluid. The upper and lower limits of the concentrations of sodium and bicarbonate in the dialysis fluid were computed. The system has not been applied clinically. Measurements of any electrolyte concentrations have not been made.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion</h3>\u0000 \u0000 <p>This system makes the treatment of profound dysnatremias, metabolic acid–base disorders, and combined dysnatremias and metabolic acid–base disorders feasible. The clinical application of the system demands prior in vitro or ex vivo studies plus fastidious and expert attention to ensure safe and dependable application.</p>\u0000 </section>\u0000 </div>","PeriodicalId":12815,"journal":{"name":"Hemodialysis International","volume":"29 3","pages":"319-326"},"PeriodicalIF":1.2,"publicationDate":"2025-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/hdi.13205","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143573794","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unveiling Challenges Hindering the Growth of Home Dialysis in Finland: Insights From 40 Years of Experience 揭示阻碍芬兰家庭透析发展的挑战:来自40年经验的见解。
IF 1.2 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2025-03-06 DOI: 10.1111/hdi.13213
B. Fuentes Huertas, M. Eskola, J. Helve, M. Prats Valencia, R. Muroma-Karttunen, P. Finne, F. Ortiz

Introduction

Home dialysis has been associated with better patient survival compared to in-center hemodialysis. Finland has over 40 years of experience with home dialysis. Despite sustained efforts, the prevalence of home dialysis has decreased in the last decade. We aimed to explore the barriers to expanding home dialysis treatments from healthcare providers' and patients' perspectives.

Methods

This is qualitative research, based on an electronic semi-structured survey directed to nephrologists, nephrology nurses, and patient associations. The survey development contemplated the main barriers shown in a conceptual framework described previously in the literature. An open-ended question was analyzed using the content analysis method.

Findings

All participants agreed that the nurse shortage and patients' several comorbidities are the main barriers. Healthcare teams were perceived as having good qualifications and interest in home dialysis. Intense transplant activity was not perceived as a barrier. Doctors and nurses believed that starting in-center hemodialysis decreases the odds of switching to home dialysis later, and patients have less motivation or reliability in their abilities. From the patient's perspective, the financial burden and the impact of home dialysis on the assistant or relative constitute critical barriers. Also, bringing hospitals home or living in small spaces is an important barrier to accepting home dialysis.

Discussion

Expanding home dialysis modalities requires boosting the home dialysis nursing pool, choosing home dialysis as a first modality, and removing the financial burden on the patients. While the rise in patients with multiple comorbidities remains unchanged, supporting relatives to prevent burnout could be beneficial.

简介:与中心血液透析相比,家庭透析与更好的患者生存相关。芬兰在家庭透析方面有40多年的经验。尽管持续努力,家庭透析的流行率在过去十年有所下降。我们旨在从医疗保健提供者和患者的角度探讨扩大家庭透析治疗的障碍。方法:这是一项定性研究,基于针对肾病学家、肾病科护士和患者协会的电子半结构化调查。调查的发展考虑了先前文献中描述的概念框架中显示的主要障碍。采用内容分析法对一个开放式问题进行分析。结果:所有参与者都认为护士短缺和患者的几种合并症是主要障碍。医疗团队被认为对家庭透析有良好的资格和兴趣。强烈的移植活动不被认为是一种障碍。医生和护士认为,开始中心血液透析会降低以后改用家庭透析的几率,而且患者对自己的能力缺乏动力或可靠性。从患者的角度来看,经济负担和家庭透析对助手或亲属的影响构成了关键障碍。此外,把医院带回家或住在狭小的空间里是接受家庭透析的一个重要障碍。讨论:扩大家庭透析模式需要扩大家庭透析护理池,选择家庭透析作为第一模式,并消除患者的经济负担。虽然患有多种合并症的患者人数的增加保持不变,但支持亲属预防倦怠可能是有益的。
{"title":"Unveiling Challenges Hindering the Growth of Home Dialysis in Finland: Insights From 40 Years of Experience","authors":"B. Fuentes Huertas,&nbsp;M. Eskola,&nbsp;J. Helve,&nbsp;M. Prats Valencia,&nbsp;R. Muroma-Karttunen,&nbsp;P. Finne,&nbsp;F. Ortiz","doi":"10.1111/hdi.13213","DOIUrl":"10.1111/hdi.13213","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Home dialysis has been associated with better patient survival compared to in-center hemodialysis. Finland has over 40 years of experience with home dialysis. Despite sustained efforts, the prevalence of home dialysis has decreased in the last decade. We aimed to explore the barriers to expanding home dialysis treatments from healthcare providers' and patients' perspectives.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This is qualitative research, based on an electronic semi-structured survey directed to nephrologists, nephrology nurses, and patient associations. The survey development contemplated the main barriers shown in a conceptual framework described previously in the literature. An open-ended question was analyzed using the content analysis method.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Findings</h3>\u0000 \u0000 <p>All participants agreed that the nurse shortage and patients' several comorbidities are the main barriers. Healthcare teams were perceived as having good qualifications and interest in home dialysis. Intense transplant activity was not perceived as a barrier. Doctors and nurses believed that starting in-center hemodialysis decreases the odds of switching to home dialysis later, and patients have less motivation or reliability in their abilities. From the patient's perspective, the financial burden and the impact of home dialysis on the assistant or relative constitute critical barriers. Also, bringing hospitals home or living in small spaces is an important barrier to accepting home dialysis.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion</h3>\u0000 \u0000 <p>Expanding home dialysis modalities requires boosting the home dialysis nursing pool, choosing home dialysis as a first modality, and removing the financial burden on the patients. While the rise in patients with multiple comorbidities remains unchanged, supporting relatives to prevent burnout could be beneficial.</p>\u0000 </section>\u0000 </div>","PeriodicalId":12815,"journal":{"name":"Hemodialysis International","volume":"29 3","pages":"275-283"},"PeriodicalIF":1.2,"publicationDate":"2025-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/hdi.13213","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143569140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis and Management of Perivenous Tissue Pain in the Outflow Tract of Arteriovenous Fistulas During Dialysis 透析过程中动静脉瘘流出道周围静脉组织疼痛的分析与处理。
IF 1.2 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2025-03-05 DOI: 10.1111/hdi.13212
Chenwei Wang, Ruibin Zhang, Xiao Wang, Xiuxiu Liu, Xiaoping Wang, Qingzhen Gao

Background

Pain is a prevalent cause of medical consultation among dialysis patients, severely impacting both treatment outcomes and quality of life. This study focuses on a specific yet underexplored type of pain—delayed and progressive perivenous tissue pain in the outflow tract of arteriovenous fistulas (AV fistula) during dialysis. The aim is to summarize its clinical features, investigate its underlying mechanisms, and evaluate the effectiveness of various treatments, ultimately providing new insights into pain management.

Methods

This study included 36 patients who experienced delayed and progressive perivenous tissue pain in the outflow tract of AV fistulas during dialysis. Pain features were systematically summarized, and the AV fistula status was comprehensively evaluated through general observation, physical examination, and imaging. A series of trial interventions were employed to further explore the underlying mechanisms of pain. Based on these findings, appropriate treatment strategies were identified and implemented, with therapeutic outcomes monitored over a 12-month follow-up.

Findings

The specific pain may be closely associated with venous hypertension. Ultrasonography identified high-flow fistulas in 18 patients, while angiography revealed varying degrees of outflow vein stenosis in 23 patients. Five patients with slightly elevated fistula blood flow and no significant stenosis underwent bandage compression therapy. Thirty-one patients with markedly increased blood flow and/or outflow vein stenosis received ultrasound-guided flow restriction surgery, percutaneous transluminal angioplasty, or combined therapies. All patients achieved pain relief, with no recurrence during the follow-up period.

Conclusions

This study systematically investigates perivenous tissue pain in the outflow tract of AV fistula during dialysis. Venous hypertension is likely the primary underlying cause of this condition. Treatment options, including bandage compression, flow restriction surgery, percutaneous transluminal angioplasty, and combined therapies, effectively alleviate the tissue pain.

背景:疼痛是透析患者就诊的普遍原因,严重影响治疗结果和生活质量。本研究的重点是透析期间动静脉瘘流出道(AV瘘)的一种特定但尚未被充分探索的疼痛延迟和进行性静脉周围组织疼痛。目的是总结其临床特征,探讨其潜在机制,并评估各种治疗的有效性,最终为疼痛管理提供新的见解。方法:本研究包括36例在透析过程中发生房室瘘流出道延迟和进行性静脉周围组织疼痛的患者。系统总结疼痛特征,通过一般观察、体格检查、影像学等综合评价房瘘状态。我们采用了一系列试验干预措施来进一步探索疼痛的潜在机制。根据这些发现,确定并实施了适当的治疗策略,并在12个月的随访中监测了治疗结果。结果:特异性疼痛可能与静脉高压密切相关。超声检查发现18例患者有高流量瘘管,血管造影显示23例患者有不同程度的流出静脉狭窄。5例瘘血流量轻微升高且无明显狭窄的患者行绷带压迫治疗。31例血流明显增加和/或流出静脉狭窄的患者接受了超声引导下的限流手术、经皮腔内血管成形术或联合治疗。所有患者均获得疼痛缓解,随访期间无复发。结论:本研究系统地探讨了透析期间房室瘘流出道的静脉周围组织疼痛。静脉高压可能是这种情况的主要潜在原因。治疗方案包括绷带压迫、限流手术、经皮腔内血管成形术和联合治疗,可有效缓解组织疼痛。
{"title":"Analysis and Management of Perivenous Tissue Pain in the Outflow Tract of Arteriovenous Fistulas During Dialysis","authors":"Chenwei Wang,&nbsp;Ruibin Zhang,&nbsp;Xiao Wang,&nbsp;Xiuxiu Liu,&nbsp;Xiaoping Wang,&nbsp;Qingzhen Gao","doi":"10.1111/hdi.13212","DOIUrl":"10.1111/hdi.13212","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Pain is a prevalent cause of medical consultation among dialysis patients, severely impacting both treatment outcomes and quality of life. This study focuses on a specific yet underexplored type of pain—delayed and progressive perivenous tissue pain in the outflow tract of arteriovenous fistulas (AV fistula) during dialysis. The aim is to summarize its clinical features, investigate its underlying mechanisms, and evaluate the effectiveness of various treatments, ultimately providing new insights into pain management.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This study included 36 patients who experienced delayed and progressive perivenous tissue pain in the outflow tract of AV fistulas during dialysis. Pain features were systematically summarized, and the AV fistula status was comprehensively evaluated through general observation, physical examination, and imaging. A series of trial interventions were employed to further explore the underlying mechanisms of pain. Based on these findings, appropriate treatment strategies were identified and implemented, with therapeutic outcomes monitored over a 12-month follow-up.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Findings</h3>\u0000 \u0000 <p>The specific pain may be closely associated with venous hypertension. Ultrasonography identified high-flow fistulas in 18 patients, while angiography revealed varying degrees of outflow vein stenosis in 23 patients. Five patients with slightly elevated fistula blood flow and no significant stenosis underwent bandage compression therapy. Thirty-one patients with markedly increased blood flow and/or outflow vein stenosis received ultrasound-guided flow restriction surgery, percutaneous transluminal angioplasty, or combined therapies. All patients achieved pain relief, with no recurrence during the follow-up period.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>This study systematically investigates perivenous tissue pain in the outflow tract of AV fistula during dialysis. Venous hypertension is likely the primary underlying cause of this condition. Treatment options, including bandage compression, flow restriction surgery, percutaneous transluminal angioplasty, and combined therapies, effectively alleviate the tissue pain.</p>\u0000 </section>\u0000 </div>","PeriodicalId":12815,"journal":{"name":"Hemodialysis International","volume":"29 3","pages":"294-302"},"PeriodicalIF":1.2,"publicationDate":"2025-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143569062","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unexplained Fever in a Hemodialysis Patient Possibly due to Cat Scratch Disease Opportunistic Infection 一例血液透析患者不明原因发热,可能由猫抓病引起。
IF 1.2 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2025-03-05 DOI: 10.1111/hdi.13223
Beyza Doğan, İbrahim Güney, Ethem Ömeroğlu

Introduction

Cat Scratch Disease, caused by the bacterium Bartonella henselae, typically manifests with fever, headache, anorexia, weight loss, tender lymphadenopathy, and other systemic symptoms. Transmission commonly occurs through a cat scratch or bite. The clinical course varies depending on the patient's immune status, notably in individuals with conditions such as renal failure. While generally localized, Cat Scratch Disease can occasionally present as a systemic illness with diverse manifestations. This report aims to elucidate the etiology of fever of unknown origin in hemodialysis patients, focusing on the case of a 30-year-old female.

Methods

A 30-year-old female patient, who routinely undergoes hemodialysis (HD) three times a week for four hours at the hemodialysis unit, was admitted to our service for further evaluation and treatment due to an infectious disease clinic presentation. She is now under close observation and management in our inpatient department.

Findings

The patient's presenting symptoms included fever, arthralgia, night sweats, and weight loss, refractory to empirical antibiotic and broad-spectrum antimicrobial therapy. Physical examination revealed lymphadenopathy and splenomegaly. Laboratory investigations demonstrated elevated C-reactive protein and procalcitonin levels. Ultrasound imaging revealed reactive lymphadenopathy in multiple regions. Following the exclusion of bacterial, viral, and mycobacterial infections, including tuberculosis, a diagnosis of lymphoma was considered. However, a subsequent lymph node biopsy revealed non-caseating granulomatous lymphadenitis, a histopathological finding consistent with Cat Scratch Disease.

Discussion

Although rare, Cat Scratch Disease should be considered in the differential diagnosis of fever of unknown origin in patients with chronic kidney disease undergoing hemodialysis.

猫抓病是由亨塞巴尔通体引起的猫抓病,主要表现为发热、头痛、厌食、体重减轻、淋巴结压痛等全身性症状。传播通常通过猫的抓伤或咬伤发生。临床病程因患者的免疫状态而异,特别是在患有肾功能衰竭等疾病的个体中。虽然猫抓病通常是局部的,但偶尔也会表现为具有多种表现的全身性疾病。本报告旨在阐明血液透析患者不明原因发热的病因学,重点报道一名30岁女性病例。方法:一名30岁女性患者,因感染性疾病的临床表现而入院接受血液透析(HD),每周3次,每次4小时。她目前在我住院部接受密切观察和管理。结果:患者表现为发热、关节痛、盗汗、体重减轻,经验性抗生素和广谱抗菌药物治疗无效。体格检查显示淋巴结病变及脾肿大。实验室调查显示c反应蛋白和降钙素原水平升高。超声显示多部位反应性淋巴结病变。排除细菌、病毒和分枝杆菌感染(包括肺结核)后,诊断为淋巴瘤。然而,随后的淋巴结活检显示非干酪化肉芽肿性淋巴结炎,组织病理学发现与猫抓病一致。讨论:猫抓病虽然罕见,但在进行血液透析的慢性肾病患者不明原因发热的鉴别诊断中应考虑猫抓病。
{"title":"Unexplained Fever in a Hemodialysis Patient Possibly due to Cat Scratch Disease Opportunistic Infection","authors":"Beyza Doğan,&nbsp;İbrahim Güney,&nbsp;Ethem Ömeroğlu","doi":"10.1111/hdi.13223","DOIUrl":"10.1111/hdi.13223","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Cat Scratch Disease, caused by the bacterium <i>Bartonella henselae</i>, typically manifests with fever, headache, anorexia, weight loss, tender lymphadenopathy, and other systemic symptoms. Transmission commonly occurs through a cat scratch or bite. The clinical course varies depending on the patient's immune status, notably in individuals with conditions such as renal failure. While generally localized, Cat Scratch Disease can occasionally present as a systemic illness with diverse manifestations. This report aims to elucidate the etiology of fever of unknown origin in hemodialysis patients, focusing on the case of a 30-year-old female.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A 30-year-old female patient, who routinely undergoes hemodialysis (HD) three times a week for four hours at the hemodialysis unit, was admitted to our service for further evaluation and treatment due to an infectious disease clinic presentation. She is now under close observation and management in our inpatient department.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Findings</h3>\u0000 \u0000 <p>The patient's presenting symptoms included fever, arthralgia, night sweats, and weight loss, refractory to empirical antibiotic and broad-spectrum antimicrobial therapy. Physical examination revealed lymphadenopathy and splenomegaly. Laboratory investigations demonstrated elevated C-reactive protein and procalcitonin levels. Ultrasound imaging revealed reactive lymphadenopathy in multiple regions. Following the exclusion of bacterial, viral, and mycobacterial infections, including tuberculosis, a diagnosis of lymphoma was considered. However, a subsequent lymph node biopsy revealed non-caseating granulomatous lymphadenitis, a histopathological finding consistent with Cat Scratch Disease.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion</h3>\u0000 \u0000 <p>Although rare, Cat Scratch Disease should be considered in the differential diagnosis of fever of unknown origin in patients with chronic kidney disease undergoing hemodialysis.</p>\u0000 </section>\u0000 </div>","PeriodicalId":12815,"journal":{"name":"Hemodialysis International","volume":"29 3","pages":"419-422"},"PeriodicalIF":1.2,"publicationDate":"2025-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143569138","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Can Bioimpedance Analysis Be Used to Estimate Absolute Blood Volume in Hemodialysis Patients? 生物阻抗分析可用于估算血液透析患者的绝对血容量吗?
IF 1.2 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2025-03-05 DOI: 10.1111/hdi.13217
Joachim Kron, John Volkenandt, Stefanie Broszeit, Til Leimbach, Susanne Kron

Introduction

Under physiological conditions, blood volume and extracellular volume are in a ratio of 1–3, even in hemodialysis patients. The question therefore arises: can blood volume be inferred from the bioimpedance analysis data? The aim of the study was to compare the blood volumes calculated from extracellular volume determined by bioimpedance analysis data to the actually measured blood volumes.

Methods

Immediately before treatment, extracellular volume and volume overload were evaluated by bioimpedance spectroscopy. The actual blood volume was determined by indicator dilution, using an on-line infusate bolus and subsequent calculation with the data from the relative blood volume monitor. Alternatively, blood volume was calculated from extracellular volume divided by 3 and compared to the measured blood volume.

Findings

Overall, there were no significant differences between measured (5.56 ± 1.47 L) and calculated (5.79 ± 1.30 L) blood volumes. However, intra-individually, there were very large discrepancies with a range of −1.409 to 1.450 L. Median absolute deviation was 382 mL corresponding to 6.2 mL/kg. The differences between measured and calculated blood volumes correlated significantly (r = −0.98; p < 0.001) with the blood to extracellular volume ratio.

Discussion

In almost half of patients, blood volume can be inferred from bioimpedance data with sufficient certainty. But the greater the deviation from the physiological blood to extracellular volume ratio of 1–3, the more the calculated blood volumes differ from the measured values. For this reason, bioimpedance data should not be used uncritically to set the ultrafiltration.

在生理条件下,血容量与细胞外体积的比例为1-3,即使在血液透析患者中也是如此。因此,问题出现了:血容量可以从生物阻抗分析数据推断出来吗?本研究的目的是比较由生物阻抗分析数据确定的细胞外体积计算出的血容量与实际测量的血容量。方法:治疗前用生物阻抗法测定细胞外体积和容量过载。实际血容量通过指标稀释测定,使用在线输液,随后根据相对血容量监测仪的数据计算。或者,用细胞外体积除以3计算血容量,并与测量的血容量进行比较。结果:总体而言,测量血容量(5.56±1.47 L)与计算血容量(5.79±1.30 L)之间无显著差异。然而,在个体内部,差异非常大,范围为-1.409 ~ 1.450 L。绝对偏差中位数为382 mL,对应于6.2 mL/kg。血容量测量值与计算值之间的差异显著相关(r = -0.98;p讨论:在几乎一半的患者中,可以从生物阻抗数据充分确定地推断出血容量。但与生理血/细胞外体积比1-3的偏差越大,计算出的血容量与实测值的差异越大。因此,生物阻抗数据不应不加鉴别地用于设置超滤。
{"title":"Can Bioimpedance Analysis Be Used to Estimate Absolute Blood Volume in Hemodialysis Patients?","authors":"Joachim Kron,&nbsp;John Volkenandt,&nbsp;Stefanie Broszeit,&nbsp;Til Leimbach,&nbsp;Susanne Kron","doi":"10.1111/hdi.13217","DOIUrl":"10.1111/hdi.13217","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Under physiological conditions, blood volume and extracellular volume are in a ratio of 1–3, even in hemodialysis patients. The question therefore arises: can blood volume be inferred from the bioimpedance analysis data? The aim of the study was to compare the blood volumes calculated from extracellular volume determined by bioimpedance analysis data to the actually measured blood volumes.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Immediately before treatment, extracellular volume and volume overload were evaluated by bioimpedance spectroscopy. The actual blood volume was determined by indicator dilution, using an on-line infusate bolus and subsequent calculation with the data from the relative blood volume monitor. Alternatively, blood volume was calculated from extracellular volume divided by 3 and compared to the measured blood volume.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Findings</h3>\u0000 \u0000 <p>Overall, there were no significant differences between measured (5.56 ± 1.47 L) and calculated (5.79 ± 1.30 L) blood volumes. However, intra-individually, there were very large discrepancies with a range of −1.409 to 1.450 L. Median absolute deviation was 382 mL corresponding to 6.2 mL/kg. The differences between measured and calculated blood volumes correlated significantly (<i>r</i> = −0.98; <i>p</i> &lt; 0.001) with the blood to extracellular volume ratio.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion</h3>\u0000 \u0000 <p>In almost half of patients, blood volume can be inferred from bioimpedance data with sufficient certainty. But the greater the deviation from the physiological blood to extracellular volume ratio of 1–3, the more the calculated blood volumes differ from the measured values. For this reason, bioimpedance data should not be used uncritically to set the ultrafiltration.</p>\u0000 </section>\u0000 </div>","PeriodicalId":12815,"journal":{"name":"Hemodialysis International","volume":"29 3","pages":"398-403"},"PeriodicalIF":1.2,"publicationDate":"2025-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143569063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Purulent Pericarditis as an Initial Manifestation of Infective Endocarditis in a Hemodialysis Patient: A Case Report 脓性心包炎是血液透析患者感染性心内膜炎的初始表现:1例报告。
IF 1.2 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2025-03-05 DOI: 10.1111/hdi.13219
Abraham Edgar Gracia-Ramos, Antonio Cortés-Ortíz, Cecilio Morales-Flores, Lourdes Alejandra Quintero-Arias

Introduction

Infective endocarditis can present with a wide range of cardiac and extra-cardiac symptoms. However, purulent pericarditis as a presenting sign has rarely been documented in the literature.

Case Description

We present a case of a 47-year-old woman on hemodialysis who presented to the emergency department due to dyspnea and edema in her lower extremities. A chest X-ray revealed an enlarged cardiac silhouette, while a computed tomography (CT) scan showed a large pericardial effusion. A transthoracic echocardiogram indicated vegetation on the tricuspid valve and pericardial effusion, with echocardiographic signs of cardiac tamponade. Emergent drainage of the pericardial space was performed, during which purulent material was obtained. Methicillin-resistant Staphylococcus aureus was identified in blood cultures collected upon admission and in the cultures from the pericardial effusion. The patient received intensive antibiotic therapy; however, despite the treatment and after a complicated hospital course, she succumbed to the illness.

Conclusion

Diagnosing purulent pericarditis in hemodialysis patients with infective endocarditis requires a high level of suspicion because typical symptoms of pericarditis are uncommon, and there is a tendency to initially attribute nonspecific constitutional symptoms to the underlying infection itself. Aggressive treatment with pericardial drainage and appropriate antibiotic therapy may prevent catastrophic outcomes.

感染性心内膜炎可表现为广泛的心脏和心脏外症状。然而,化脓性心包炎作为表现的征象在文献中很少有记载。病例描述:我们提出一个47岁的妇女血液透析谁提出了急诊科由于呼吸困难和水肿在她的下肢。胸部x线显示心脏轮廓增大,而计算机断层扫描显示大量心包积液。经胸超声心动图显示三尖瓣赘生物和心包积液,超声心动图显示心脏填塞征象。紧急引流心包间隙,在此过程中获得化脓性物质。在入院时收集的血液培养和心包积液培养中发现了耐甲氧西林金黄色葡萄球菌。患者接受强化抗生素治疗;然而,尽管接受了治疗,经过了复杂的住院治疗,她还是死于这种疾病。结论:血液透析合并感染性心内膜炎患者的化脓性心包炎的诊断需要高度的怀疑,因为典型的心包炎症状并不常见,并且最初倾向于将非特异性体质症状归因于潜在感染本身。积极的心包引流治疗和适当的抗生素治疗可以防止灾难性的后果。
{"title":"Purulent Pericarditis as an Initial Manifestation of Infective Endocarditis in a Hemodialysis Patient: A Case Report","authors":"Abraham Edgar Gracia-Ramos,&nbsp;Antonio Cortés-Ortíz,&nbsp;Cecilio Morales-Flores,&nbsp;Lourdes Alejandra Quintero-Arias","doi":"10.1111/hdi.13219","DOIUrl":"10.1111/hdi.13219","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Infective endocarditis can present with a wide range of cardiac and extra-cardiac symptoms. However, purulent pericarditis as a presenting sign has rarely been documented in the literature.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Case Description</h3>\u0000 \u0000 <p>We present a case of a 47-year-old woman on hemodialysis who presented to the emergency department due to dyspnea and edema in her lower extremities. A chest X-ray revealed an enlarged cardiac silhouette, while a computed tomography (CT) scan showed a large pericardial effusion. A transthoracic echocardiogram indicated vegetation on the tricuspid valve and pericardial effusion, with echocardiographic signs of cardiac tamponade. Emergent drainage of the pericardial space was performed, during which purulent material was obtained. Methicillin-resistant \u0000 <i>Staphylococcus aureus</i>\u0000 was identified in blood cultures collected upon admission and in the cultures from the pericardial effusion. The patient received intensive antibiotic therapy; however, despite the treatment and after a complicated hospital course, she succumbed to the illness.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Diagnosing purulent pericarditis in hemodialysis patients with infective endocarditis requires a high level of suspicion because typical symptoms of pericarditis are uncommon, and there is a tendency to initially attribute nonspecific constitutional symptoms to the underlying infection itself. Aggressive treatment with pericardial drainage and appropriate antibiotic therapy may prevent catastrophic outcomes.</p>\u0000 </section>\u0000 </div>","PeriodicalId":12815,"journal":{"name":"Hemodialysis International","volume":"29 3","pages":"414-418"},"PeriodicalIF":1.2,"publicationDate":"2025-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143569064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Hemodialysis International
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1